Observed Signal · Nov 5, 2026 · earnings · Source: SEC API · Impact: 4.5/5

Oscar Health Reports Q3 2026 Net Income of $167.3M as Revenue Surges 72%

Executive Signal Summary

Oscar Health, Inc. reported strong third-quarter 2026 financial results, achieving total revenue of $5.14 billion, up 72.1% from $2.99 billion in Q3 2025. The company delivered a net income attributable to Oscar Health of $167.3 million ($0.49 per diluted share), reversing a net loss of $137.5 million in the prior-year period. Growth was driven by disciplined pricing strategies and a 27.2% year-over-year expansion in effectuated membership to approximately 2.69 million. Underwriting profitability improved notably, with the Medical Loss Ratio (MLR) decreasing by 450 basis points year-over-year to 84.0%, while the SG&A expense ratio improved by 350 basis points to 14.0% due to operating leverage. Additionally, Oscar announced a notice to redeem its remaining $35 million aggregate principal amount of 7.25% convertible senior notes due 2031 by December 31, 2026.

Polaris7 AgentPolaris7 Strategic Assessment
High Confidence

The filing documents sustained profitability and operating leverage with over $5 billion in quarterly revenue, expanding membership to 2.7 million, and maintaining disciplined MLR improvement despite evolving regulatory frameworks.

SIGNAL RADAR

Track Oscar Signals & Market Shifts in Real-Time

Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your Polaris7 workspace to monitor these entities.

Start Monitoring
Verified primary sourcesAutomated briefingsInstant watchlist setup

Key Takeaways & Evidence Grounding

  • Total revenue reached $5.14 billion in Q3 2026, a 72.1% year-over-year increase compared to $2.99 billion in Q3 2025.
  • Operating income turned positive to $178.0 million, and net income reached $167.3 million compared to an operating loss of $129.3 million and a net loss of $137.5 million in Q3 2025.
  • Medical Loss Ratio (MLR) improved by 450 basis points year-over-year to 84.0%, down from 88.5% in Q3 2025.
  • Effectuated membership reached 2.69 million as of September 30, 2026, representing 27.2% growth over the prior-year period.
  • Q3 2026 total revenue reached $5.14B, up 72.1% from $2.99B in Q3 2025, driven by membership growth and rate increases.
  • Q3 2026 net income attributable to Oscar was $167.3M ($0.49 diluted EPS) compared to a net loss of $137.5M in Q3 2025.
  • Medical Loss Ratio (MLR) improved by 450 basis points year-over-year to 84.0%, while the SG&A expense ratio declined to 14.0%.
  • Effectuated membership grew 27.2% year-over-year to 2.69 million members as of September 30, 2026.
  • Oscar Health announced financial results for the third quarter ended September 30, 2026.
  • The filing was furnished pursuant to Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits).
Primary Source Grounding & Direct Attribution
Direct Origin Attribution
Primary Reporting: SEC API•Published: Nov 5, 2026

Related Market Signals & Shifts

Recent verified developments and strategic activity across this market segment.

FundingOct 13, 2026

Pluto Security Raises $42M to Secure Enterprise AI Tools

Pluto Security, a startup specializing in securing enterprise AI tool usage, has announced $42 million in total funding, including an $8.5 million seed round led by TLV Partners and a $34 million Series A led by Jump Capital. The company, which emerged from stealth, helps organizations gain visibility and control over how employees use AI tools, detecting risks in AI skills, extensions, and MCP servers. Since launching sales in April, Pluto has achieved over $2 million in annual recurring revenue and secured more than 30 enterprise customers, including Oscar Health, Workato, Sixt, and AlphaSense. The startup's platform monitors AI agent behavior in real time, can intervene in ongoing sessions, and integrates with endpoint security systems. It also offers Plutonium, a free community platform for checking AI component risks, which has become a significant source of inbound leads. The new capital will fund product development, security research, and U.S. expansion.

Read assessment
Product & Platform LaunchOct 7, 2026

The making of a brand: Oscar Health redesigns its family of brands around individual choice

CMO Kristen Prestano explains how Oscar Health’s new business model connects insurance, healthcare shopping and technology through one consumer promise.

Read assessment
Product & Platform LaunchSep 28, 2026

15 mind-blowing stats that prove CHOICE will reshape employer-sponsored healthcare

Oscar's article argues that the traditional group health insurance model is failing, citing statistics on premium increases and household concerns. It promotes CHOICE Arrangements (formerly ICHRA) as a new model shifting from employer-managed risk to personalization and cost predictability. The article claims that 15 statistics prove this transformation is unstoppable, though only a few are detailed in the provided text.

Read assessment
Executive Briefing & Watchlist

Receive all future signals for Oscar & competitors in your briefing

Never miss material M&A deals, leadership changes, account wins, or product rollouts. Polaris7 monitors 20,000+ primary sources 24/7, delivering verified telemetry directly into your executive briefing.

Daily primary source scansCurated executive briefingsUnsubscribe anytime